Navigation Links
Kite Pharma Completes $35 Million Series A Preferred Stock Financing
Date:5/15/2013

nd manufacturing activities of eACT products directed to hematological and solid tumor indications."

In connection with the financing, Farah Champsi , Managing Director of Alta Partners, and Ran Nussbaum, Managing Partner of Pontifax, have joined Kite's Board of Directors. "We are pleased to welcome Farah and Ran, who will be adding their expertise to a very active and engaged Board," said Arie Belldegrun. "Their experience within the life sciences industry will be valuable to us as Kite enters its next stage of development and growth."

"Kite's eACT technology has the potential to provide cancer patients with a treatment that offers a significant and durable impact on their disease," said Farah Champsi . "The product pipeline directed to different tumor types, combined with the company's experienced management team, positions Kite to become a leader in this breakthrough therapeutic modality. I am excited to work again with Drs. Belldegrun and Jakobovits to realize the potential of this product platform."

About the eACT Platform
Clinical evidence has demonstrated that a patients' peripheral blood T cells, which have been engineered with T cell receptor (TCRs) and Chimeric Antigen Receptors (CARs) that recognize tumor specific molecules, can traffic directly to the tumor, become activated upon engagement with the tumor antigen, and selectively eradicate tumors. Clinical studies performed at the National Cancer Institute using these types of engineered peripheral blood T cells have been associated with significant and durable objective clinical responses in cancer patients with advanced metastatic disease, including those with refractory melanoma, sarcoma, lymphoma and leukemia. These encouraging results highlight eACT as an emerging therapeutic modality that could provide new personalized targeted therapy options for cancer patients spanning the spectrum of disease from its early st
'/>"/>

SOURCE Kite Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. To Present At The UBS Global Health Care Conference
2. Savient Pharmaceuticals Reports First Quarter 2013 Financial Results
3. The Law Offices of Marc S. Henzel Announces Class Action Lawsuit Against Aveo Pharmaceuticals, Inc. and Certain Officers -- (Nasdaq: AVEO) was filed on behalf of stockholders
4. PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022
5. PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022
6. PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
7. Halo Pharma And Altus Formulation Announce New Formal Collaboration
8. Astellas Joins the National Pharmaceutical Council
9. Callidus Biopharma Announces $4.6 million in Series A Financing to Pursue Orphan Disease Therapies
10. Research Solutions Launches New Software-as-a-Service Compliance Solution for Pharmaceutical Companies
11. Sunshine Act Compliance Simplified for Pharmaceutical Drug Manufacturers with New Medical ePrint Solution from Reprints Desk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 27, 2015 Research ... addition of the  "North America Mammography Market ... 2019)"  report to their offering. ... is a detailed type of imaging that ... breasts. A mammography exam, called a mammogram, ...
(Date:5/27/2015)... -- Sequenom, Inc. (NASDAQ: SQNM ), a life sciences ... of innovative products and services, today announced that its ... operations in Grand Rapids, Michigan ... , North Carolina.  Sequenom Laboratories, cystic fibrosis carrier screen ... North Carolina laboratory location.  "The ...
(Date:5/27/2015)... YORK , May 27, 2015 PharmaPoint: Type ... 2023 Summary Type 1 diabetes (T1D) is an ... islet, which means that the body can no longer produce ... evolving continuously, as at present, no other treatment can be ... A variety of insulin analogs with different times of action ...
Breaking Medicine Technology:North America Mammography Market - Growth, Trends And Forecasts (2014 - 2019) 2Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 2Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4
... 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky ... leading fully integrated pharmaceutical company producing over-the-counter drugs in the ... the fourth quarter and fiscal year ended December 31, 2010. ... 2010 Highlights Total revenues decreased by ...
... 2011 Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ... Trademark Office (USPTO) has issued U.S. Patent 7,906,489 which ... treatment with fidaxomicin.  The patent, which is eligible for ... Book, also received a term adjustment of an additional ...
Cached Medicine Technology:China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 2China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 3China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 4China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 5China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 6China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 7China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 8China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 9China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 10China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 11China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 12China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 13China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 14Optimer Pharmaceuticals Announces Issuance of Key Patent Covering Fidaxomicin Methods of Use as a Treatment of Clostridium difficile infection 2
(Date:5/27/2015)... 27, 2015 “We are honored to ... executive vice president and vice president of clinical affairs ... possible allows us to provide comprehensive care to more ... , SSCHC provides clinical care and behavioral health services ... in 2014, many of whom took advantage of the ...
(Date:5/27/2015)... 2015 Continuing its commitment to finding ... in the community, SmartPractice® donated $25,000 to ... Lincoln). SmartPractice Vice President of Human Resources Meg Mosher ... $25,000 check to Paulla Miller, Sherry Gage, Dr. Linda ... Research Center on April 30. The center is located ...
(Date:5/27/2015)... 2015 In today's healthcare landscape, where ... can be challenging for doctors and hospitals to keep ... , Austin-based HealthTronics, Inc. is offering ... medical therapies for clinically sophisticated applications. The company has ... of Laser Ventures, Inc ., a mobile laser ...
(Date:5/27/2015)... The new http://www.carsonenergy.com includes extensive ... consider oil and gas investing, the substantial tax benefits ... industry news, IRA investing, definitions and acronyms, info-graphics and ... and experience is now in one central location, for ... to access 24 hours a day, 7 days a ...
(Date:5/27/2015)... 27, 2015 In support of a ... issue of the Journal of American Geriatrics Society about ... obesity, Bedford Commons OB-GYN P.A . is reiterating ... sweetener-flavored beverages. , To examine the relationship between ... San Antonio Longitudinal Study of Aging (SALSA) tracked the ...
Breaking Medicine News(10 mins):Health News:Sixteenth Street Community Health Centers To Expand Primary Care and Behavioral Health Services Through $1 Million Grant From Aurora's Better Together Fund 2Health News:SmartPractice Donates $25,000 to HonorHealth Breast Health and Research Center 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3Health News:Carson Energy Launches Next Generation Investor Website 2Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2
... Solos Endoscopy, Inc. (OTCPK:,SNDY) is pleased to announce ... for the period ending June 30, 2008. Revenues,generated through ... $151,347.53 for the comparable period in 2007. The Company,saw ... $13,242 compared with just,over $8,000 at the end of ...
... there are no safe substitutes for authentic,FDA approved ... unbranded,unapproved and counterfeit cosmetic injectables are a threat ... Coalition for Injectable Safety. "The,growing acceptance of cosmetic ... comes with consumer cautions," says Coalition,leader, plastic surgeon ...
... October 7, 2008 Extreme heat events (EHE), or ... human mortality in the United States, responsible for more ... combined. These events, and other climate-related changes in the ... in the November issue of the American Journal ...
... Hong Kong Celebrates a Wealth of Innovative Products, ... world leader in,research and development, announces today that it ... October 2008 at Gordon Wu Hall, B P,International House ... Founded in 1902 in Minnesota, United States, 3M has ...
... 8 A recent study comparing eight,leading ... prescription packages that could impact patient safety ... are contained in them., Pharmacy Healthcare ... Pittsburgh, PA, conducted a study to analyze ...
... Orthopedics, Inc. today,announced the first human use of ... The landmark case was performed by Dr. Karin,Buttner-Janz, ... the Vivantes,Clinic in Berlin, Germany, and involved a ... developed symptomatic facet joint,degeneration. "Generally in this situation ...
Cached Medicine News:Health News:Solos Endoscopy, Inc. Posts First Six Months Financials of 2008 on Pinksheets.com 2Health News:Illegal Botox Scammers a Public Threat 2Health News:Illegal Botox Scammers a Public Threat 3Health News:Illegal Botox Scammers a Public Threat 4Health News:Illegal Botox Scammers a Public Threat 5Health News:Climate change will affect public health -- a call to action 2Health News:Climate change will affect public health -- a call to action 3Health News:3M Innovation Day 2Health News:3M Innovation Day 3Health News:Test Results from Pharmacy Healthcare Solutions Show not all Prescription Packaging is Created Equal 2Health News:Archus Orthopedics Performs First Facet Replacement Procedure With an Artificial Disc 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: